Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer

Clinical trial NCT07772882 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07772882
Sponsor: Rebecca Arend
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum Resistant Ovarian Cancer Fallopian Tube Cancers Peritoneal Carcinoma

Start date: 2026-09-01
Primary completion: 2028-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.